Prof. Polina Stepensky Explains The CAR (Chimeric Antigen Receptor) T-Cell Therapy.
Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today that they have entered into the research and license agreement with Immix BioPharma, for the development and commercialization of novel tissue specific therapeutics based on anti-BCMA CAR-T cells targeting plasma cell. This technology has been developed as the result of a collaboration between Prof. Polina Stepensky, of Hadassah Medical Center, Jerusalem and Prof. Cyrille J. Cohen, of Bar-Ilan University, Ramat Gan. Dr. Shlomit Kfir-Erenfeld and Dr. Nathalie Asherie, of Hadassah Medical Center, and Ortal Harush, of Bar-Ilan University, also participated in the research.
For more information visit Yahoo! Finance
Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms
Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.
Giving birth in the Labor and Delivery Department at the Rady Mother and Child Centre at Hadassah Mount Scopus
The proud grandmother, Dina, is a veteran midwife. She has stood by and supported…
Prof. Yoram Weiss of Hadassah Hospital Discusses the COVID-19 Delta Variant
Prof. Yoram Weiss of Hadassah Hospital Discusses the COVID-19 Delta Variant
Prof. Yoram Weiss of Hadassah Hospital was recently quoted in the Washington Post about the COVID-19 Delta variant and how even though infection rates in Israel are increasing, very few of them are becoming seriously ill.
Israeli Health Minister Visits Shamir Medical Centre (Assaf Harofeh) Emergency Department
BREAKING NEWS: Israeli Health Minister Visits Shamir Medical Centre (Assaf Harofeh) Emergency Department
Following an evening of heavy rocket fire across southern and central Israel, Health Minister, Yuli Edelstein, visited the state-of-the-art Emergency Department and Intensive Care Unit at Shamir Medical Centre (Assaf Harofeh).
The CHW Debbie Eisenberg and Gary Levene Pediatric Intensive Care Unit (PICU), Shamir Medical Centre – Alma’s Story
Weekly Story: The CHW Debbie Eisenberg and Gary Levene Pediatric Intensive Care Unit (PICU), Shamir Medical Centre – Alma’s Story
Little Alma woke up in the middle of the night crying with severe stomach pains. Her mother, Jana, tried everything to soothe her cries. As her condition worsened, Jana rushed her to the emergency room at Shamir Medical Centre.
Flooded with Thank You Letters
Weekly Story: Flooded with Thank You Letters
The Shamir Medical Centre (Assaf Harofeh) has been flooded with Thank You letters from patients and families affected by COVID-19. Read more for a letter to the hospital staff from Galia, a patient who was recently treated for a severe respiratory condition caused by COVID-19.
Hadassah Experts Advise Vienna Nursing Home on Vaccination Protocols
Weekly Story: Hadassah Experts Advise Vienna Nursing Home on Vaccination Protocols
On January 11, 2021, Hadassah Medical Center, along with Hadassah International, offered a webinar on optimum vaccination protocols for nursing home residents to the director and medical director of Maimonides Zentrum home for the aged, located in Vienna, Austria
Behind the Scenes of Israel’s COVID-19 Vaccination Campaign
Weekly Story: Behind the Scenes of Israel’s COVID-19 Vaccination Campaign
While the success of the COVID-19 vaccination campaign depends on countless professionals and dedicated frontline staff, Israelis were delighted to hear of one woman who played a pivotal role behind the scenes- Benita Elkon Baitner.
Hadassah Medical Centre reported success in the first phase of the Israeli COVID-19 Vaccine trial
Weekly Story: Hadassah Medical Centre reported success in the first phase of the Israeli COVID-19 Vaccine trial
The first clinical phase of testing the Israeli Biological Institute’s corona vaccine was completed at Hadassah Ein Kerem when the final dose was given to the 40th trial participant. Read more to learn about the first phase, and learn about one of the trial participants.
